Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$13.05 +0.94%

+$0.15 today

Market cap
$331.67M
Beta
0.48
P/E (TTM)
9.3
EPS (TTM)
$1.22
52W Low $11.98High $20.56

Volume 0.04M

Average 0.03M

CPH.TO Total Non-current Liabilities

All obligations due after more than one year.

Cipher Pharmaceuticals Inc.TSX: CPH.TO

Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Total non-current liabilities falls 99.6% from a year ago

Total non-current liabilities stood at $165.12K at the end of Q1 FY2026, down 99.6% from a year earlier and down 96.8% from the prior quarter. Over 3 fiscal years it compounded at +151.6% a year.

Context

  • Total non-current liabilities amounted to 0.1% of total assets at the end of Q1 FY2026, down 24.6 pp from a year earlier.
  • Total non-current liabilities increased in 1 of the last 3 fiscal years.

What to watch

Whether total non-current liabilities keeps falling in the next quarterly balance sheet after a -99.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$165.12K-96.8% QoQ
Last fiscal yearDec 2025
$5.21M-87.1% YoY
Year agoMar 2025
$40.25M-99.6% since
Total Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-99.6%——
1 year-87.1%——
3-year CAGR+151.6%——
5-year CAGR——
10-year CAGR——

Total Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
5.21M USD
Year-over-year change
-87.1%
4-year CAGR
+83.4%

Total Non-current Liabilities vs competitors

How CPH.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so total non-current liabilities is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -99.6% is the lowest of 8, against a peer median of -15.3%.
  • Total non-current liabilities amounts to 0.1% of total assets for CPH.TO, versus a peer median of 23.5%.
CPH.TO Competitors
Total Non-current Liabilities for CPH.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TSND.TOTerrAscend Corp.Mar 2026$390.75M USD+9.0%+5.7%71.1%
WEED.TOCanopy Growth CorporationMar 2026CA$262.7M CAD-21.8%-33.0%23.5%
GUD.TOKnight Therapeutics Inc.Mar 2026CA$106.88M CAD+94.3%+9.1%9.8%
OGI.TOOrganiGram Holdings Inc.Mar 2026CA$60.75M CAD-15.3%—11.7%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026$24.5M USD-44.2%-0.5%34.2%
ACB.TOAurora Cannabis Inc.Mar 2026CA$22.32M CAD-83.2%-48.9%3.7%
EDT.TOSpectral Medical Inc.Mar 2026CA$9.85M CAD+87.0%+6.5%215.2%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$165.12K USD-99.6%+151.6%0.1%
Peer median (excluding CPH.TO) —-15.3%+2.6%23.5%

Competitors are the stored peer set for CPH.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents20.55M28.84M39.83M17.84M7.48M
Short-term Investments00000
Net Receivables6.66M6.8M5.09M13.86M11.19M
Inventory1.65M2.15M2.98M5.79M8.18M
Other Current Assets00378K01.16M
Total Current Assets29.33M38.16M48.27M38.48M28M
Property, Plant & Equipment (Net)501K481K402K680K567.96K
Goodwill15.71M15.71M15.71M17.45M17.42M
Intangible Assets3.65M2.75M1.76M78.75M71.88M
Long-term Investments19.85M18.94M000
Tax Assets2.47M16.67M19.89M26.76M38.12M
Other Non-current Assets(19.85M)(18.94M)19.89M386K235.57K
Total Non-current Assets22.32M35.62M37.76M124.03M128.22M
Total Assets51.65M73.78M86.03M162.51M156.22M
Account Payables5.56M4.11M4.64M5.87M6.38M
Short-term Debt00000
Tax Payables6.23M4.9M054K0
Deferred Revenue450K257K519K13.31M18.35M
Other Current Liabilities6.68M5.16M00(27.93K)
Total Current Liabilities12.29M9.37M5.25M19.87M25M
Long-term Debt00040M4.99M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities460K327K259K40.3M5.21M
Total Liabilities12.75M9.7M5.51M60.17M30.2M
Common Stock18.12M17.72M18.01M27.68M27.81M
Retained Earnings25.2M50.52M66.27M77.65M99.93M
Accumulated OCI(9.51M)(9.51M)(9.51M)(9.51M)(9.5M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity38.9M64.08M80.52M102.34M126.01M
Total Debt516K428K353K40.58M5.49M
Net Debt(20.03M)(28.41M)(39.47M)22.74M(1.98M)

Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Intrinsic Alpha fair value

Locked

Current Price

$13.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.